Physician profile
Jonathan D Tward
NPI 1144415969
$113,858.57
in general payments reported to CMS, 2019-2025
13 companies · $35K in 2025
The $35K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2021: $9,231 · 2022: $13K · 2023: $13K · 2024: $20K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Travel and Lodging: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,750 · Food and Beverage: $3,972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $49,445.51 |
| Travel and Lodging | $10,618.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,750.00 |
| Food and Beverage | $3,972.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $28,007.11 | 2021-2024 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $27,178.55 | 2019-2025 | |
| Bioprotect Medical, INC. | $20,325.60 | 2024-2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $8,530.26 | 2019-2024 | Spaceoar Vue System - 10ml |
| Progenics Pharmaceuticals, INC. | $6,754.12 | 2023-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $6,598.93 | 2019 | |
| Pfizer INC. | $6,017.75 | 2023-2025 | |
| Blue Earth Diagnostics | $5,055.91 | 2019 | |
| Myovant Sciences INC. | $4,850.00 | 2022 | |
| Theragenics Corporation | $227.47 | 2024 | |
| Elekta, INC. | $134.26 | 2024 | |
| Novartis Pharmaceuticals Corporation | $90.50 | 2023 | |
| Siemens Medical Solutions USA, INC. | $88.11 | 2024-2025 | Bravos Afterloader System, Aria Radiation Therapy Management Software |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Tward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.